Inflammasomes and intestinal tumorigenesis

Md Hasan Zaki, Mohamed Lamkanfi, Thirumala Devi Kanneganti

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Colorectal cancer is a major health problem in developed countries. Chronic intestinal inflammation predisposes individuals to the development of colorectal cancer. The intracellular NOD-like receptors (NLRs) have emerged as crucial regulators of intestinal inflammation and colorectal tumorigenesis. Activation of several NLRs leads to the formation of a protein complex called the inflammasome, which then triggers the activation of the cysteine protease caspase-1 and the downstream maturation and secretion of the inflammatory cytokines interleukin (IL)-1β and -18. Defective inflammasome signaling in the gut contributes to colitis and colorectal tumorigenesis by increasing the permeability of the epithelial barrier, dysregulating the proliferation of epithelial cells, and inducing oncogenic mediators. In this review, we discuss our current knowledge on how the inflammasome protects against colorectal tumorigenesis.

Original languageEnglish (US)
JournalDrug Discovery Today: Disease Mechanisms
Volume8
Issue number3-4
DOIs
StatePublished - Dec 2011

Fingerprint

Inflammasomes
Carcinogenesis
Colorectal Neoplasms
Inflammation
Caspase 1
Interleukin-18
Cysteine Proteases
Colitis
Interleukin-1
Developed Countries
Permeability
Epithelial Cells
Cytokines
Health
Proteins
NLR Proteins

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Inflammasomes and intestinal tumorigenesis. / Zaki, Md Hasan; Lamkanfi, Mohamed; Kanneganti, Thirumala Devi.

In: Drug Discovery Today: Disease Mechanisms, Vol. 8, No. 3-4, 12.2011.

Research output: Contribution to journalArticle

Zaki, Md Hasan ; Lamkanfi, Mohamed ; Kanneganti, Thirumala Devi. / Inflammasomes and intestinal tumorigenesis. In: Drug Discovery Today: Disease Mechanisms. 2011 ; Vol. 8, No. 3-4.
@article{2db13c16a97545b2af57346d6db8598b,
title = "Inflammasomes and intestinal tumorigenesis",
abstract = "Colorectal cancer is a major health problem in developed countries. Chronic intestinal inflammation predisposes individuals to the development of colorectal cancer. The intracellular NOD-like receptors (NLRs) have emerged as crucial regulators of intestinal inflammation and colorectal tumorigenesis. Activation of several NLRs leads to the formation of a protein complex called the inflammasome, which then triggers the activation of the cysteine protease caspase-1 and the downstream maturation and secretion of the inflammatory cytokines interleukin (IL)-1β and -18. Defective inflammasome signaling in the gut contributes to colitis and colorectal tumorigenesis by increasing the permeability of the epithelial barrier, dysregulating the proliferation of epithelial cells, and inducing oncogenic mediators. In this review, we discuss our current knowledge on how the inflammasome protects against colorectal tumorigenesis.",
author = "Zaki, {Md Hasan} and Mohamed Lamkanfi and Kanneganti, {Thirumala Devi}",
year = "2011",
month = "12",
doi = "10.1016/j.ddmec.2011.11.003",
language = "English (US)",
volume = "8",
journal = "Drug Discovery Today: Disease Mechanisms",
issn = "1740-6765",
publisher = "Elsevier Limited",
number = "3-4",

}

TY - JOUR

T1 - Inflammasomes and intestinal tumorigenesis

AU - Zaki, Md Hasan

AU - Lamkanfi, Mohamed

AU - Kanneganti, Thirumala Devi

PY - 2011/12

Y1 - 2011/12

N2 - Colorectal cancer is a major health problem in developed countries. Chronic intestinal inflammation predisposes individuals to the development of colorectal cancer. The intracellular NOD-like receptors (NLRs) have emerged as crucial regulators of intestinal inflammation and colorectal tumorigenesis. Activation of several NLRs leads to the formation of a protein complex called the inflammasome, which then triggers the activation of the cysteine protease caspase-1 and the downstream maturation and secretion of the inflammatory cytokines interleukin (IL)-1β and -18. Defective inflammasome signaling in the gut contributes to colitis and colorectal tumorigenesis by increasing the permeability of the epithelial barrier, dysregulating the proliferation of epithelial cells, and inducing oncogenic mediators. In this review, we discuss our current knowledge on how the inflammasome protects against colorectal tumorigenesis.

AB - Colorectal cancer is a major health problem in developed countries. Chronic intestinal inflammation predisposes individuals to the development of colorectal cancer. The intracellular NOD-like receptors (NLRs) have emerged as crucial regulators of intestinal inflammation and colorectal tumorigenesis. Activation of several NLRs leads to the formation of a protein complex called the inflammasome, which then triggers the activation of the cysteine protease caspase-1 and the downstream maturation and secretion of the inflammatory cytokines interleukin (IL)-1β and -18. Defective inflammasome signaling in the gut contributes to colitis and colorectal tumorigenesis by increasing the permeability of the epithelial barrier, dysregulating the proliferation of epithelial cells, and inducing oncogenic mediators. In this review, we discuss our current knowledge on how the inflammasome protects against colorectal tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=84860339104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860339104&partnerID=8YFLogxK

U2 - 10.1016/j.ddmec.2011.11.003

DO - 10.1016/j.ddmec.2011.11.003

M3 - Article

VL - 8

JO - Drug Discovery Today: Disease Mechanisms

JF - Drug Discovery Today: Disease Mechanisms

SN - 1740-6765

IS - 3-4

ER -